Free Trial

Aprea Therapeutics (APRE) Short Interest Ratio & Short Volume

→ Wall Street Legend Warns: 'A Strange Day Is Coming to America' (From Chaikin Analytics) (Ad)
Free APRE Stock Alerts
$4.97
-0.33 (-6.23%)
(As of 05/28/2024 ET)
Compare
Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestTrends

Aprea Therapeutics Short Interest Data

Current Short Interest
32,400 shares
Previous Short Interest
90,700 shares
Change Vs. Previous Month
-64.28%
Dollar Volume Sold Short
$187,920.00
Short Interest Ratio
1.1 Days to Cover
Last Record Date
May 15, 2024
Outstanding Shares
5,430,000 shares
Float Size
4,780,000 shares
Short Percent of Float
0.68%
Today's Trading Volume
19,634 shares
Average Trading Volume
24,936 shares
Today's Volume Vs. Average
79%
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook
Short Selling Aprea Therapeutics ?

Sign up to receive the latest short interest report for Aprea Therapeutics and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History
Short Interest ChartDays to Cover ChartShort Percent of Float Chart

APRE Short Interest Over Time

APRE Days to Cover Over Time

APRE Percentage of Float Shorted Over Time

Aprea Therapeutics Short Interest History

Export to Excel
Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
5/15/202432,400 shares $187,920.00 -64.3%0.7%1.1 $5.80
4/30/202490,700 shares $462,570.00 -5.7%1.9%3 $5.10
4/15/202496,200 shares $570,466.00 -9.1%2.0%2.9 $5.93
3/31/2024105,800 shares $707,802.00 -9.7%2.4%3.1 $6.69
3/15/2024117,100 shares $724,849.00 +66.8%3.8%3.3 $6.19
2/29/202470,200 shares $593,892.00 -11.6%2.2%2.1 $8.46
2/15/202479,400 shares $450,992.00 -20.5%2.5%5.6 $5.68
1/31/202499,900 shares $516,483.00 -17.0%3.2%7.6 $5.17
1/15/2024120,300 shares $671,274.00 +5.7%3.8%10.7 $5.58
12/31/2023113,800 shares $534,860.00 -1.6%3.6%10.4 $4.70
12/15/2023115,700 shares $444,288.00 -1.6%3.7%11.6 $3.84
11/30/2023117,600 shares $428,064.00 -2.4%3.8%11.4 $3.64
11/15/2023120,500 shares $477,180.00 +4.1%3.9%11.4 $3.96
10/31/2023115,800 shares $394,878.00 -3.3%3.7%9.4 $3.41
10/15/2023119,700 shares $629,622.00 +0.9%3.8%7.5 $5.26
9/30/2023118,600 shares $494,146.90 -5.7%3.8%2.6 $4.17
9/15/2023125,800 shares $503,200.00 -1.3%4.0%2.8 $4.00
8/31/2023127,500 shares $470,475.00 -5.0%4.1%2.8 $3.69
8/15/2023134,200 shares $483,120.00 -9.1%4.3%2.8 $3.60
7/31/2023147,700 shares $457,870.00 +427.5%4.7%3.2 $3.10
7/15/202328,000 shares $87,640.00 +9.4%0.9%0.6 $3.13
6/30/202325,600 shares $80,640.00 +161.2%0.8%2 $3.15
6/15/20239,800 shares $33,418.00 -58.5%0.3%0.7 $3.41
5/31/202323,600 shares $90,860.00 -4.8%0.8%1.8 $3.85
5/15/202324,800 shares $90,768.00 -30.3%0.8%1.7 $3.66
4/30/202335,600 shares $141,154.00 +20.3%1.1%2.3 $3.97
4/15/202329,600 shares $121,360.00 +46.5%0.9%2 $4.10
3/31/202320,200 shares $89,688.00 -56.2%0.6%1.2 $4.44
3/15/202346,100 shares $240,642.00 +31.0%1.4%2.9 $5.22
2/28/202335,200 shares $180,576.00 -3.3%1.0%2.5 $5.13
2/15/202336,400 shares $283,920.00 -94.4%1.9%2.8 $7.80
1/31/2023646,700 shares $324,320.05 -24.3%N/A3 $0.50
1/15/2023854,200 shares $416,507.92 +6.2%N/A4.1 $0.49
12/30/2022804,300 shares $266,223.30 +9.9%N/A5.7 $0.33
12/15/2022731,700 shares $278,046.00 -0.8%N/A5.7 $0.38
11/30/2022737,800 shares $306,187.00 -9.3%N/A5 $0.42
11/15/2022813,300 shares $333,453.00 -8.2%N/A5.4 $0.41
10/31/2022885,700 shares $593,330.43 -9.0%4.5%7.2 $0.67
10/15/2022973,700 shares $740,012.00 +18.5%5.0%7 $0.76
9/30/2022821,800 shares $534,170.00 -6.1%4.2%3.1 $0.65
Wall Street Legend Warns: "A Strange Day Is Coming to America" (Ad)

Get Your Cash Out of U.S. Banks Immediately Man who predicted 2023 bank run warns a historic financial reset is coming. Get out of cash and into a new vehicle 50 years in the making.

Click here to learn more.
9/15/2022875,500 shares $773,154.05 +24.7%4.5%1.2 $0.88
8/31/2022701,900 shares $557,378.79 +3.1%3.6%1 $0.79
8/15/2022681,100 shares $626,612.00 -14.9%3.5%0.9 $0.92
7/31/2022800,200 shares $768,192.00 -61.5%4.1%0.9 $0.96
7/15/20222,080,000 shares $2.33 million +154.3%11.8%2.3 $1.12
6/30/2022817,900 shares $613,425.00 -14.7%4.6%1 $0.75
6/15/2022958,400 shares $797,388.80 -18.1%5.8%2.5 $0.83
5/31/20221,170,000 shares $979,875.00 +22.0%7.1%2.6 $0.84
5/15/2022959,100 shares $1.14 million +2.1%5.7%2.3 $1.19
4/30/2022939,700 shares $1.37 million -9.6%5.5%2.9 $1.46
4/15/20221,040,000 shares $1.71 million +7.3%6.1%2.9 $1.64
3/31/2022969,500 shares $1.80 million +11.0%5.8%2.6 $1.86
3/15/2022873,700 shares $1.52 million -5.8%5.2%2 $1.74
2/28/2022927,800 shares $1.61 million -5.6%5.6%1.5 $1.74
2/15/2022983,000 shares $1.84 million +30.8%5.9%1.5 $1.87
1/31/2022751,400 shares $1.57 million +35.6%4.8%1 $2.09
1/15/2022554,300 shares $1.46 million -17.6%3.6%0.7 $2.64
12/31/2021672,500 shares $1.93 million -36.6%4.3%0.7 $2.87
12/15/20211,060,000 shares $3.65 million +43.9%6.8%0.9 $3.44
11/30/2021736,600 shares $2.98 million +12.9%4.8%0.5 $4.04
11/15/2021652,200 shares $3.14 million -27.2%4.2%0.4 $4.82
10/29/2021895,400 shares $4.43 million +7.4%5.9%0.6 $4.95
10/15/2021833,500 shares $4.28 million +3.5%5.5%0.6 $5.14
9/30/2021805,300 shares $4.12 million +171.0%5.3%0.4 $5.11
9/15/2021297,200 shares $1.38 million -57.3%2.0%0.2 $4.64
8/31/2021695,800 shares $3.21 million -24.2%4.6%0.2 $4.62
8/13/2021917,400 shares $3.35 million -27.2%6.0%0.3 $3.65
7/30/20211,260,000 shares $5.33 million +15.6%8.5%0.4 $4.23
7/15/20211,090,000 shares $5.55 million -42.3%7.4%0.3 $5.09
6/30/20211,890,000 shares $9.22 million +29.5%12.8%0.6 $4.88
6/15/20211,460,000 shares $7.08 million +2.8%9.9%0.5 $4.85
5/28/20211,420,000 shares $5.99 million -15.0%9.6%2 $4.22
5/14/20211,670,000 shares $6.76 million +17.6%11.3%2.2 $4.05
4/30/20211,420,000 shares $6.75 million -15.0%9.6%1.4 $4.75
4/15/20211,670,000 shares $7.41 million +11.3%11.7%1.3 $4.44
3/31/20211,500,000 shares $7.19 million +14.5%10.5%1 $4.79
3/15/20211,310,000 shares $7.81 million -8.4%9.2%0.7 $5.96
2/26/20211,430,000 shares $8.58 million -24.3%9.9%0.9 $6.00
2/12/20211,890,000 shares $13.89 million -2.6%12.7%1.2 $7.35
1/29/20211,940,000 shares $10.50 million +84.8%14.6%1.4 $5.41
1/15/20211,050,000 shares $5.47 million -40.3%7.9%1 $5.21
12/31/20201,760,000 shares $8.92 million +64.5%13.2%2.2 $5.07
12/15/20201,070,000 shares $30.76 million +11.6%8.0%5.9 $28.75
11/30/2020958,800 shares $25.36 million -10.4%7.2%5.7 $26.45
11/15/20201,070,000 shares $22.89 million -3.6%8.0%7.4 $21.39
10/30/20201,110,000 shares $25.09 million -0.9%8.7%9.3 $22.60
10/15/20201,120,000 shares $28.84 million -3.5%8.7%11.6 $25.75
9/30/20201,160,000 shares $27.91 million -4.1%9.3%13.4 $24.06
9/15/20201,210,000 shares $34.51 million -11.0%9.7%13.5 $28.52
8/31/20201,360,000 shares $36.86 million +0.7%10.9%9.8 $27.10
Wall Street Legend Warns: "A Strange Day Is Coming to America" (Ad)

Get Your Cash Out of U.S. Banks Immediately Man who predicted 2023 bank run warns a historic financial reset is coming. Get out of cash and into a new vehicle 50 years in the making.

Click here to learn more.
8/14/20201,350,000 shares $37.29 million -3.6%10.9%8.8 $27.62
7/31/20201,400,000 shares $38.40 million +20.7%11.4%8.7 $27.43
7/15/20201,160,000 shares $33.30 million +11.5%9.3%7.3 $28.71
6/30/20201,040,000 shares $37.92 million +36.3%8.5%7 $36.46
6/15/2020763,200 shares $23.40 million +2.6%6.2%5.6 $30.66
5/29/2020743,900 shares $19.98 million -12.5%6.2%8.4 $26.86
5/15/2020850,300 shares $29.20 million -3.0%7.1%10.3 $34.34
4/30/2020876,800 shares $29.11 million +3.5%8.4%12.2 $33.20
4/15/2020847,300 shares $28.81 million +34.0%8.1%11.3 $34.00
3/31/2020632,500 shares $21.35 million +44.6%6.2%7.7 $33.75
3/13/2020437,500 shares $14.70 million +4.2%4.3%4.8 $33.61
2/28/2020419,900 shares $14.89 million +45.8%4.1%3.7 $35.47
2/14/2020288,000 shares $9.92 million +1.6%2.8%2.5 $34.43
1/31/2020283,500 shares $9.82 million +61.4%2.8%2.5 $34.65
1/15/2020175,700 shares $6.08 million -21.3%1.7%1.5 $34.62
12/31/2019223,200 shares $8.61 million No Change2.2%1.9 $38.58

APRE Short Interest - Frequently Asked Questions

What is Aprea Therapeutics' current short interest?

Short interest is the volume of Aprea Therapeutics shares that have been sold short but have not yet been covered or closed out. As of May 15th, traders have sold 32,400 shares of APRE short. 0.68% of Aprea Therapeutics' shares are currently sold short. Learn More on Aprea Therapeutics' current short interest.

What is a good short interest ratio for Aprea Therapeutics?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. APRE shares currently have a short interest ratio of 1.0. Learn More on Aprea Therapeutics's short interest ratio.

Which institutional investors are shorting Aprea Therapeutics?

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Aprea Therapeutics: Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

What is a good short interest percentage for Aprea Therapeutics?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.68% of Aprea Therapeutics' floating shares are currently sold short.

Is Aprea Therapeutics' short interest increasing or decreasing?

Aprea Therapeutics saw a drop in short interest during the month of May. As of May 15th, there was short interest totaling 32,400 shares, a drop of 64.3% from the previous total of 90,700 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is Aprea Therapeutics' float size?

Aprea Therapeutics currently has issued a total of 5,430,000 shares. Some of Aprea Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Aprea Therapeutics currently has a public float of 4,780,000 shares.

How does Aprea Therapeutics' short interest compare to its competitors?

0.68% of Aprea Therapeutics' shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Aprea Therapeutics: Enlivex Therapeutics Ltd. (1.24%), Apollomics, Inc. (0.20%), Oncternal Therapeutics, Inc. (0.87%), Bolt Biotherapeutics, Inc. (8.82%), Biora Therapeutics, Inc. (3.85%), ImmunoPrecise Antibodies Ltd. (0.93%), JanOne Inc. (2.92%), Lisata Therapeutics, Inc. (0.16%), Viracta Therapeutics, Inc. (2.42%), Unity Biotechnology, Inc. (2.02%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.81 billion), Charter Communications, Inc. ($3.30 billion), Occidental Petroleum Co. ($3.10 billion), General Motors ($2.84 billion), Moderna, Inc. ($2.77 billion), AppLovin Co. ($2.22 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.16 billion), Tractor Supply ($2.12 billion), and Williams-Sonoma, Inc. ($2.12 billion). View all of the most shorted stocks.

What does it mean to sell short Aprea Therapeutics stock?

Short selling APRE is an investing strategy that aims to generate trading profit from Aprea Therapeutics as its price is falling. APRE shares are trading down $0.33 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Aprea Therapeutics?

A short squeeze for Aprea Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of APRE, which in turn drives the price of the stock up even further.

How often is Aprea Therapeutics' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including APRE, twice per month. The most recent reporting period available is May, 15 2024.



More Short Interest Resources from MarketBeat

Related Companies:
Short Interest Tools:
This page (NASDAQ:APRE) was last updated on 5/28/2024 by MarketBeat.com Staff

From Our Partners
The #1 Crypto That You Don’t Own… Yet
Crypto 101 Media
WARNING about the death of the U.S. dollar…
Colonial Metals
Exposed: 10 CENT Crypto to Explode May 20th?
True Market Insiders
Tim Sykes’ Urgent Trade Alert: “Make this move now”
Timothy Sykes
Biggest Prediction of My 50-Year Career on Wall Street
Chaikin Analytics
He Is Giving Away Bitcoin
Crypto Swap Profits
Elon’s New Device is About to Shock the World
InvestorPlace
Digitizing the $11T commodities sector with one tiny stock
Resource Stock Digest